Lilly v. Comm'r of Internal Revenue

Decision Date28 May 1985
Docket NumberDocket No. 5113-76.
Citation84 T.C. 996,84 T.C. No. 65
PartiesELI LILLY and COMPANY and SUBSIDIARIES, Petitioners v. COMMISSIONER OF INTERNAL REVENUE, Respondent
CourtU.S. Tax Court

OPINION TEXT STARTS HERE

+---------------------------------------------------------------------+
                ¦ELI LILLY AND COMPANY AND SUBSIDIARIES, PETITIONERS                  ¦
                +---------------------------------------------------------------------¦
                ¦v. COMMISSIONER OF INTERNAL REVENUE, RESPONDENT                      ¦
                +---------------------------------------------------------------------¦
                ¦Docket No. 5113-76. Filed May 28, 1985.                              ¦
                +---------------------------------------------------------------------¦
                ¦CONTENTS                                                             ¦
                +---------------------------------------------------------------------¦
                ¦                                                                ¦Page¦
                +----------------------------------------------------------------+----¦
                ¦Headnote                                                        ¦999 ¦
                +----------------------------------------------------------------+----¦
                ¦Introduction and Statement of Issues                            ¦1001¦
                +----------------------------------------------------------------+----¦
                ¦Findings of Fact                                                ¦1002¦
                +----------------------------------------------------------------+----¦
                ¦I. History and Background of Eli Lilly & Co.                    ¦1002¦
                +----------------------------------------------------------------+----¦
                ¦A. Petitioner                                                   ¦1002¦
                +----------------------------------------------------------------+----¦
                ¦B. Lilly P.R.                                                   ¦1004¦
                +----------------------------------------------------------------+----¦
                ¦II. History and Background of Darvon and Darvon-N Products      ¦1004¦
                +----------------------------------------------------------------+----¦
                ¦A. Propoxyphene and Propoxyphene Hydrochloride                  ¦1004¦
                +----------------------------------------------------------------+----¦
                ¦B. Propoxyphene Napsylate                                       ¦1006¦
                +----------------------------------------------------------------+----¦
                ¦C. Success of Darvon and Darvon-N Products                      ¦1007¦
                +----------------------------------------------------------------+----¦
                ¦III. Manufacture of Darvon and Darvon-N Products                ¦1009¦
                +----------------------------------------------------------------+----¦
                ¦A. Overview of Petitioner's Manufacturing Operations            ¦1009¦
                +----------------------------------------------------------------+----¦
                ¦B. Manufacture of Darvon Products                               ¦1010¦
                +----------------------------------------------------------------+----¦
                ¦C. Manufacture of Darvon-N Products                             ¦1012¦
                +----------------------------------------------------------------+----¦
                ¦D. Development of Manufacturing Know-How                        ¦1012¦
                +----------------------------------------------------------------+----¦
                ¦1. Chemical Manufacture                                         ¦1012¦
                +----------------------------------------------------------------+----¦
                ¦2. Pharmaceutical Manufacture                                   ¦1014¦
                +----------------------------------------------------------------+----¦
                ¦E. Foreign Manufacture of Propoxyphene Products                 ¦1015¦
                +----------------------------------------------------------------+----¦
                ¦IV. Historical Development of the Puerto Rican Operations of    ¦    ¦
                +----------------------------------------------------------------+----¦
                ¦Petitioner and Lilly P.R.                                       ¦1015¦
                +----------------------------------------------------------------+----¦
                ¦A. Puerto Rico's ‘Operation Bootstrap‘                          ¦1015¦
                +----------------------------------------------------------------+----¦
                ¦B. Petitioner's 1961-62 Study of Possible Puerto Rican          ¦    ¦
                +----------------------------------------------------------------+----¦
                ¦Operations                                                      ¦1016¦
                +----------------------------------------------------------------+----¦
                ¦C. Petitioner's Second Puerto Rican Study 1965-66               ¦1017¦
                +----------------------------------------------------------------+----¦
                ¦V. Lilly P.R.'s Puerto Rican Tax Exemptions                     ¦1025¦
                +----------------------------------------------------------------+----¦
                ¦VI. Background and Documents Concerning Lilly P.R.              ¦1027¦
                +----------------------------------------------------------------+----¦
                ¦A. Organization of Lilly P.R. and Initial Capitalization        ¦1027¦
                +----------------------------------------------------------------+----¦
                ¦B. Technical Assistance Agreement                               ¦1027¦
                +----------------------------------------------------------------+----¦
                ¦C. Private Letter Ruling                                        ¦1028¦
                +----------------------------------------------------------------+----¦
                ¦D. Assignment of Patents and Manufacturing Know-How             ¦1031¦
                +----------------------------------------------------------------+----¦
                ¦E. Distribution Agreements                                      ¦1034¦
                +----------------------------------------------------------------+----¦
                ¦F. Joint Research Agreement                                     ¦1035¦
                +----------------------------------------------------------------+----¦
                ¦G. Agreements Regarding Empty Capsules                          ¦1037¦
                +----------------------------------------------------------------+----¦
                ¦VII. Lilly P.R.'s Manufacturing Activities                      ¦1037¦
                +----------------------------------------------------------------+----¦
                ¦A. Temporary Leased Facility                                    ¦1037¦
                +----------------------------------------------------------------+----¦
                ¦B. Carolina Facility                                            ¦1038¦
                +----------------------------------------------------------------+----¦
                ¦C. Mayaguez Facility                                            ¦1039¦
                +----------------------------------------------------------------+----¦
                ¦D. Personnel                                                    ¦1040¦
                +----------------------------------------------------------------+----¦
                ¦1. Organization of Initial Work Force                           ¦1040¦
                +----------------------------------------------------------------+----¦
                ¦2. Training of Employees                                        ¦1041¦
                +----------------------------------------------------------------+----¦
                ¦3. Board of Directors, Officers, and Management                 ¦    ¦
                +----------------------------------------------------------------+----¦
                ¦Committees                                                      ¦1042¦
                +----------------------------------------------------------------+----¦
                ¦4. 1971-73 Lilly P.R. Personnel                                 ¦1042¦
                +----------------------------------------------------------------+----¦
                ¦E. Manufacturing Activities 1971-73                             ¦1042¦
                +----------------------------------------------------------------+----¦
                ¦1. Production Planning                                          ¦1042¦
                +----------------------------------------------------------------+----¦
                ¦2. Chemical Manufacturing at Mayaguez                           ¦1043¦
                +----------------------------------------------------------------+----¦
                ¦3. Pharmaceutical Manufacturing at Carolina                     ¦1045¦
                +----------------------------------------------------------------+----¦
                ¦F. Manufacturing Tickets and Related Procedures                 ¦1046¦
                +----------------------------------------------------------------+----¦
                ¦G. Raw Material Purchases                                       ¦1048¦
                +----------------------------------------------------------------+----¦
                ¦H. Equipment Purchases                                          ¦1049¦
                +----------------------------------------------------------------+----¦
                ¦I. Technical Assistance                                         ¦1049¦
                +----------------------------------------------------------------+----¦
                ¦J. Quality Control                                              ¦1050¦
                +----------------------------------------------------------------+----¦
                ¦K. Sample and Identi-dose Packaging                             ¦1051¦
                +----------------------------------------------------------------+----¦
                ¦VIII. Petitioner's Marketing Operations                         ¦1051¦
                +----------------------------------------------------------------+----¦
                ¦A. Introduction                                                 ¦1051¦
                +----------------------------------------------------------------+----¦
                ¦B. Organization                                                 ¦1052¦
                +----------------------------------------------------------------+----¦
                ¦1. Marketing Research and Marketing Planning                    ¦1052¦
                +----------------------------------------------------------------+----¦
                ¦2. Sales Force                                                  ¦1053¦
                +----------------------------------------------------------------+----¦
                ¦C. Regulation of Promotional Claims                             ¦1055¦
                +----------------------------------------------------------------+----¦
                ¦D. Marketing of Darvon and Darvon-N Products                    ¦1056¦
                +----------------------------------------------------------------+----¦
                ¦E. Pricing of Darvon and Darvon-N Products                      ¦1056¦
                +----------------------------------------------------------------+----¦
                ¦F. Significance of Marketing Intangibles                        ¦1058¦
                +----------------------------------------------------------------+----¦
                ¦IX. Petitioner's Research and Development Activities
...

To continue reading

Request your trial
25 cases
  • G. D. Searle & Co. v. Comm'r of Revenue
    • United States
    • U.S. Tax Court
    • February 4, 1987
    ...SCO failed to similarly qualify under section 931 in 1974.OPINIONINTRODUCTION This proceeding is a companion case to Eli Lilly & Co. v. Commissioner, 84 T.C. 996 (1985), on appeal (7th Cir., Nov. 12, 1986), (hereinafter referred to as Eli Lilly)12A . Like Eli Lilly, the record in this case ......
  • Inverworld, Inc. v. Commissioner, Docket No. 27089-90.
    • United States
    • U.S. Tax Court
    • June 27, 1996
    ...482 reallocations are arbitrary, capricious, or unreasonable. Sundstrand Corp. v. Commissioner, supra; Eli Lilly & Co. v. Commissioner [Dec. 42,113], 84 T.C. 996, 1131 (1985), affd. in part, revd. in part and remanded [88-2 USTC ¶ 9502] 856 F.2d 855 (7th Cir. 1988). In deciding whether the ......
  • Paccar, Inc. v. Comm'r of Internal Revenue
    • United States
    • U.S. Tax Court
    • November 13, 1985
    ...clearly reflect the income of such corporations. For a discussion of the history and purpose of section 482, see Eli Lilly & Co. v. Commissioner, 84 T.C. 996, 1115-1116 (1985); Foster v. Commissioner, 80 T.C. 34, 191-195 (1983), affd. in part and vacated on another issue in part 756 F.2d 14......
  • Coca-Cola Co. v. Comm'r
    • United States
    • U.S. Tax Court
    • November 18, 2020
    ...shows that neither side is correct." Eli Lilly & Co. v. Commissioner, 856 F.2d 855, 860 (7th Cir. 1988), rev'g in part on other grounds 84 T.C. 996 (1985); see Amazon.com, Inc.,Page 93148 T.C. at 163-214 (making partial allocations with respect to buy-in payment for taxpayer's website techn......
  • Request a trial to view additional results
1 firm's commentaries
  • Medtronic Part Deux: The Best Method Is Yet To Come?
    • United States
    • Mondaq United States
    • September 30, 2022
    ...v. Commr., 96 T.C. 226, 353 (1991) (citing G.D. Searle & Co. v. Commr., 88 T.C. 252, 358 (1987), and citing Eli Lilly & Co. v. Commr., 84 T.C. 996, 1131 (1985), aff'd. on this issue, rev'd in part and rem'd, 856 F.2d 855 (7th Cir. 6. Eli Lilly & Co. v. Commr., 856 F.2d 855, 860 (and the cas......
3 books & journal articles
  • Proposed section 482 regulations.
    • United States
    • Tax Executive Vol. 44 No. 5, September 1992
    • September 1, 1992
    ...that are to be independently examined under the arm's-length standard. The proposed regulations would overrule Eli Lilly v. Commissioner, 84 T.C. 996 (1985), aff'd in part, rev'd in part, and rem'd in part, 856 F.2d 855 (7th Cir. 1988), by making property contributed in a section 351 transa......
  • Selected Canadian litigation aspects of international pricing disputes: effect of proposed changes.
    • United States
    • Tax Executive Vol. 44 No. 6, November 1992
    • November 1, 1992
    ...in major pricing cases in recent years as the Courts have refused to adopt IRS case theories. See, eg., Eli Lilly and Co. v. Commissioner, 84 T.C. 996 (1985), aff'd in part, rev'd in part, rem'd, 856 F.2d 855, 860 (7th Cir. 1988); G.D. Searle & Co. v. Commissioner, 88 T.C. 252 (1987); B......
  • Temporary and proposed section 482 regulations.
    • United States
    • Tax Executive Vol. 45 No. 5, September 1993
    • September 1, 1993
    ...income from the entity who actually earned the income. (5) See, e.g., Bausch & Lomb v. Commissioner, supra; Eli Lilly v. Commissioner, 84 T.C. 996 (1985), aff'd in part, rev'd in part, and rem'd in part, 856 F. 2d 855 (7th Cir. (6) Rather than sending taxpayers on a quest for the "best"......

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT